Cargando…
Spore powder of Ganoderma lucidum for the treatment of Alzheimer disease: A pilot study
BACKGROUND: This study explored the feasible efficacy and safety of the Spore Powder of Ganoderma Lucidum (SPGL) for treating patients with Alzheimer disease (AD). METHODS: Forty-two eligible patients with AD were recruited. These patients were randomly allocated to an intervention group and a contr...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer Health
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5959386/ https://www.ncbi.nlm.nih.gov/pubmed/29742702 http://dx.doi.org/10.1097/MD.0000000000010636 |